Editing
Pathophysiology of Erectile Dysfunction
(section)
Jump to navigation
Jump to search
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
===== Antihypertensive Agents ===== * '''Almost all antihypertensive drugs have ED listed as a potential side effect''', though recent well-designed controlled clinical trials have clarified their association with ED * '''<span style="color:#ff0000">Associated with ED (3)</span>''' *# '''<span style="color:#ff0000">α2-agonists (e.g. clonidine)</span>''' *# '''<span style="color:#ff0000">Methyldopa (centrally acting antihypertensive agent)</span>''' *#'''<span style="color:#ff0000">Diuretics</span>''' *#* '''<span style="color:#ff0000">Spironolactone</span>''' is a nonselective mineralocorticoid receptor antagonist with moderate affinity for progesterone and androgen receptors. The latter property increases the likelihood of endocrine side effects, including loss of libido, gynecomastia, and impotence *#*'''<span style="color:#ff0000">Thiazides (e.g. hydrochlorothiazide)''' * '''<span style="color:#ff0000">Variably associated with ED</span>''' ** '''<span style="color:#ff0000">β-blockers</span>''' *** '''<span style="color:#ff0000">Non-selective β antagonists (e.g. propranolol, labetalol) are associated with ED</span>''' *** '''<span style="color:#ff0000">β1-selective antagonists (e.g. acebutolol, atenolol, bisoprolol, metoprolol, esmolol) are not associated with ED</span>''' *'''<span style="color:#ff0000">Not associated with ED</span>''' *# '''<span style="color:#ff0000">ACE-inhibitors</span>''' *# '''<span style="color:#ff0000">ARBs</span>''' *# '''<span style="color:#ff0000">α1-blockers</span>''' *#* May cause retrograde ejaculation *# '''<span style="color:#ff0000">Calcium channel blockers</span>''' ** '''ARBs and α-blockers may exert a positive effect of erectile function[https://onlinelibrary.wiley.com/doi/full/10.1111/j.1524-6175.2005.05285.x?sid=nlm%3Apubmed#t1 §]'''
Summary:
Please note that all contributions to UrologySchool.com may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
UrologySchool.com:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)
Navigation menu
Personal tools
Not logged in
Talk
Contributions
Create account
Log in
Namespaces
Page
Discussion
English
Views
Read
Edit
Edit source
View history
More
Search
Navigation
Main page
Clinical Tools
Guidelines
Chapters
Landmark Studies
Videos
Contribute
For Patients & Families
MediaWiki
Recent changes
Random page
Help about MediaWiki
Tools
What links here
Related changes
Special pages
Page information